The A4 study: Now is the time to join the fight to prevent Alzheimer's disease.

News

Share the A4 StudyShare on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
Linkedin

A4 Study Results: Investigational Anti-Amyloid Treatment Started Before Alzheimer’s Symptoms Did Not Slow Memory Loss

March 09, 2023
Off
Brigham & Women’s Hospital
READ MORE

Lilly Provides Update on A4 Study of Solanezumab for Preclinical Alzheimer’s Disease

March 08, 2023
Off
Eli Lilly & Company
READ MORE

Feasibility Study Conducted for A4 Trial

August 17, 2021
Off
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
READ MORE

First A4 Screening Data Paper Published

April 15, 2020
Off
National Institute on Aging
READ MORE

Her Alzheimer’s Research Includes Her Husband

October 03, 2019
Off
Wall Street Journal
READ MORE

Joining the Citizen Army

May 29, 2019
Off
WCVB
READ MORE

World’s First A4 Alzheimer’s Prevention Study Participant Celebrates Completion of Study

February 25, 2019
Off
Memory Matters
READ MORE

How Would You Respond to Your Amyloid PET Scan Result?

February 25, 2019
Off
Penn Memory Center
READ MORE

Memory Slips as Soon as Amyloid Appears, Two Decades Before Dementia

September 27, 2018
Off
AlzForum
READ MORE
12345

Categories

National Media

Local Media

Journal Articles

A4 Study Organizers

The A4 Study is a landmark public-private partnership, funded by the National Institute on Aging/NIH, Eli Lilly and Company, and several philanthropic organizations. The A4 trial is coordinated by the University of Southern California’s Alzheimer’s Therapeutic Research Institute, with study sites in multiple locations.

Quick Search

Share the A4 Study

©2019 A4 Study

Your upload was successful!